Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

LITHIUM 8 MEQ/5 ML SOLUTION

Lithium
$0.4808per ML

Strength

8 meq/5mL

Manufacturer

Advagen Pharma Ltd.

NDC

72888017246

Classification

Generic

Dosage Form

SOLUTION

Route

ORAL

Last Updated

3/18/2026

Active Ingredients

LITHIUM CITRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA218036

On Market Since

11/9/2022

Pharmacological Classes

Mood Stabilizer

Price History

1W

0.0%

1M

0.0%

3M

+0.8%

6M

+1.6%

1Y

N/A

3Y

N/A

5Y

N/A

All

+2.3%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

LAMOTRIGINE 25 MG TABLET
Generic
00904700761•Major Pharmaceuticals
$0.0294
per EA
LAMOTRIGINE 25 MG TABLET
Generic
13668004501•Torrent Pharmaceuticals Limited
$0.0294
per EA
LAMOTRIGINE 25 MG TABLET
Generic
13668004505•Torrent Pharmaceuticals Limited
$0.0294
per EA
LAMOTRIGINE 25 MG TABLET
Generic
16714019401•NorthStar Rx LLC
$0.0294
per EA
LAMOTRIGINE 25 MG TABLET
Generic
29300011101•Unichem Pharmaceuticals (USA) Inc.
$0.0294
per EA
LAMOTRIGINE 25 MG TABLET
Generic
29300011105•Unichem Pharmaceuticals (USA) Inc.
$0.0294
per EA
LAMOTRIGINE 25 MG TABLET
Generic
29300011110•Unichem Pharmaceuticals (USA) Inc.
$0.0294
per EA
LAMOTRIGINE 25 MG TABLET
Generic
51672413001•Sun Pharmaceutical Industries Inc.
$0.0294
per EA
LAMOTRIGINE 25 MG TABLET
Generic
59746024501•Jubilant Cadista Pharmaceuticals Inc.
$0.0294
per EA
LAMOTRIGINE 25 MG TABLET
Generic
59746024505•Jubilant Cadista Pharmaceuticals Inc.
$0.0294
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy